Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 11 entities : Biogen inc. save search
Eisai Presents New Analysis Of Lecanemab Clinical Efficacy Results From Phase 2b Study At Clinical Trials On Alzheimer's Disease (CTAD) Conference
Published: 2021-11-11 (Crawled : 20:00) - biospace.com/
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -0.12%
H: 0.37%
C: -0.02%
disease alzheimer ema phase 2 clinical trials results trials phase 2b trial conference alzheimer’s alzheimer's disease alzheimer's lecanemab
New Blood Test To Identify People At Risk Of Developing Alzheimer's Symptoms Will Be Used In Clinical Trial Aiming To Prevent Memory Loss
Published: 2021-11-11 (Crawled : 15:00) - biospace.com/
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -0.12%
H: 0.37%
C: -0.02%
alzheimer blood risk test trial alzheimer’s alzheimer's
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.